Bullish indicating open at $55-$60, IPO prices at $37
Investing.com - ContraFect Corp reported on Monday third quarter earnings that missed analysts' forecasts and revenue that was inline with expectations.
ContraFect Corp announced earnings per share of $-0.430 on revenue of $0.00. Analysts polled by Investing.com EPS of $-0.230 on revenue of $0.00.
ContraFect Corp 's are down 67% and is trading at $0.148 , still down 96.74% from its 52 week high of $4.54 set on Friday, June 10, 2022.
ContraFect Corp shares gained 2.71% to trade at $0.148 in intra-day trade the report.
ContraFect Corp follows other major Healthcare sector earnings this month
ContraFect Corp's report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on revenue of $23.79B, EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on revenue of $6.94B, for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar